Presumably, survival signals activated by CD86 (e.g., NF‐kB signaling pathway) or by binding to stromal cells could promote the survival of MM cells by blocking the inhibitory effect of Bcl‐2. The gene discussed is NFKB1; the disease is Miyoshi myopathy.